PDND
Phytochemical Database for Neurological Disorders
search icon
Advanced search

Phytochemical Name : Coenzyme Q10
PCNDIDC0217
Pubchem CID : 5281915
Molecular formula: C59H90O4

Molecular weight : 863.300

Canonical SMILES : CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C

Synonymes : Coenzyme Q10|ubidecarenone|303-98-0|ubiquinone-10|CoQ10|Ubiquinone 50|Neuquinon|Ubiquinone Q10|Ubiquinone|Justquinon|Neuquinone|Emitolon|Heartcin|Inokiten|Terekol|Udekinon|Coenzyme Q-10|Vitamin Q|coenzyme-Q10|Bio-Quinone Q10|Coenzyme Q 10|Luvacor|CoenzymeQ10|Unispheres Q 10|co-enzyme Q10|CoQ 10|PureSorb Q 40|Aqua Q10|Ubidecarenona|Ubidecarenonum|Ubidecarenonum [Latin]|Coenzyme Q(sub 10)|Adelir|Ubidecarenona [Spanish]|NSC 140865|CoQ(sub 10)|Ubiquinone Q(sub 10)|Oristar ubq|Q 199|ubisemiquinone|API-31510|Ube-Q|Coenzyme q-199|CCRIS 9016|Co-enzyme Q-10|C59H90O4|EINECS 206-147-9|BPM-31510|Ubidecarenone [INN:JAN]|NSC 140665|NSC-140865|Co Q10|Bpm31510|UNII-EJ27X76M46|Q 10AA|2-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione|DTXSID6046054|CHEBI:46245|EJ27X76M46|Ubidecarenone [INN:BAN:JAN:NF]|Ubidecarenone for system suitability|API 31510|NSC-140665|2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione|BP31510|NCGC00159429-02|(all-E)-2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-Cyclohexadiene-1,4-dione|2,5-Cyclohexadiene-1,4-dione, 2-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl|2,5-Cyclohexadiene-1,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-, (all-E)-|2-((all-E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone|2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone|p-Benzoquinone, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-|Bio-Quinon|DTXCID4026054|C59-H90-O4|2,5-Cyclohexadiene-1,4-dione, 2-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-|CAS-303-98-0|CoQ10;Ubiquinone-10|ubisemiquinone radical|unbiquinone|Armolipid|Kudesan|Mitocor|Akvion|NSC140865|Liquid-Q|Ubiquinone-Q10|ubiquinone(10)|NCGC00095322-03|KanekaQ10|2,5-Cyclohexadiene-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl-|2-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione|2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione|27696-12-4|all-trans-ubiquinone|Li-Q-Sorb|Q-Gel|Adelir (TN)|Coenzymeq10,(S)|Kaneka Q10|MFCD00042919|Co Enzyme Q-10|UBIQUINONE [INCI]|CoQ10; Ubiquinone-10|Coenzyme Q10(CoQ10)|Aqua Q 10L10|D01ZUA|D0OT1A|UBIDECARENONE [DSC]|UBIDECARENONE [INN]|UBIDECARENONE [JAN]|Ubidecarenone (JP17/INN)|Q-Gel 100|SCHEMBL19858|MLS000028745|UBIDECARENONE [MART.]|UBIQUINONE 50 [MI]|COENZYME Q10 [VANDF]|UBIDECARENONE [USP-RS]|UBIDECARENONE [WHO-DD]|CHEMBL454801|(non-labelled)Coenzyme Q10-d5|SCHEMBL11901691|API-31510 (iv)|Coenzyme Q10 (oral formulation)|EX-A973|Coenzyme Q10, analytical standard|HY-N0111|Tox21_111660|Tox21_113394|UBIDECARENONE [EP MONOGRAPH]|LMPR02010001|s2398|Coenzyme Q10, >=98% (HPLC)|AKOS015897104|AKOS015951232|AC-4352|CS-O-08364|DB09270|2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-tetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl)-5,6-dimethoxy-3-methyl-[1,4]benzoquinone|2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-DECAMETHYL-2,6,10,14,18,22,26,30,34,38-TETRACONTADECAEN-1-YL]-5,6-DIMETHOXY-3-METHYL-2,5-CYCLOHEXADIENE-1,4-DIONE|AS-13341|LS-15517|LS-40331|Q 10|Q-10|SMR000058651|C1971|Coenzyme Q10 (oral formulation), Receptagen|CS-0007796|CoQ10 platform technology, Ryan (Receptagen)|C-7060|D01065|A936217|EN300-21680292|Q321285|UBIDECARENONE FOR SYSTEM SUITABILITY [USP-RS]|Ubidecarenone, European Pharmacopoeia (EP) Reference Standard|Ubidecarenone, United States Pharmacopeia (USP) Reference Standard|2-DECA(3-METHYLBUT-2-ENYLENE)-5,6-DIMETHOXY-3-METHYL-P-BENZOQUINONE|Ubidecarenone for system suitability, European Pharmacopoeia (EP) Reference Standard|Ubidecarenone for System Suitability, United States Pharmacopeia (USP) Reference Standard|(all-E)-2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-2,5-Cyclohexadiene-1,4-dione|2,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-|2,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-, (all-E)-|2,5-ciclohexadieno-1,4-diona, 2-[(2e,6e,10e,14e,18e,22e,26e,30e,34e)-3,7,11,15,19,23,27,31,35,39-decametil-2,6,10,14,18,22,26,30,34,38-tetracontadecaen-1-il]-5,6-dimetoxi-3-metil-|2,5-Cyclohexadiene-1,4-dione, 2-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaen-1-yl)-5,6-dimethoxy-3-methyl-|2,5-Cyclohexadiene-1,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-, (all trans)-|2-((all-E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione|2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone, (all trans)-|2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecenyl)-5,6-dimethoxy-3-methyl-1,4-benzoquinone|2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl- 2,5-Cyclohexadiene-1,4-dione|2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methylbenzo-1,4-quinone #|p-Benzoquinone,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-

Structure
3D structure 2D structure
5281915
Predicted properties (NCBI Pubchem)

Physicochemical Properties